Français
ItalianoBond Johnson & Sons 0.65% ( XS1411535799 ) in EUR
| Issuer | Johnson & Sons |
| Market price | 100 % ▲ |
| Country |  United States
|
| ISIN code |
 XS1411535799 ( in EUR )
|
| Interest rate | 0.65% per year ( payment 1 time a year) |
| Maturity | 19/05/2024 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 100 000 EUR |
| Total amount | 750 000 000 EUR |
| Cusip | 478160CA0 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Johnson & Johnson is a multinational corporation that manufactures and sells a wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health products. This financial analysis focuses on the recently matured Johnson & Johnson bond, identified by ISIN XS1411535799 and CUSIP 478160CA0. Issued from the United States by Johnson & Johnson, a globally diversified healthcare conglomerate renowned for its pharmaceuticals, medical devices, and consumer health products, this particular debt instrument was denominated in EUR. The bond carried a modest annual interest rate of 0.65% and had a substantial total issuance size of EUR 750,000,000, with a minimum investment threshold set at EUR 100,000. As of May 19, 2024, this bond reached its full maturity, and its principal amount was reimbursed to bondholders at 100% of its face value, signifying the successful conclusion of its lifecycle. |